FSTR News Alert L.B. Foster Company (FSTR) 51.81 11/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
L.B. Foster Company (FSTR) 51.81 $FSTR

Uptrend Call Working As LB Foster Stock Rises 12.0% (FSTR)
Comtex SmarTrend(R) - Tue Nov 11, 9:35AM CST
SmarTrend identified an Uptrend for LB Foster (NASDAQ:FSTR) on October 16th, 2014 at $47.49. In approximately 4 weeks, LB Foster has returned 11.99% as of today's recent price of $53.18.
FSTR: 51.81 (-1.69)

LB Foster Downgraded to Strong Sell on Weak Q3 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:50PM CST
On Nov 8, 2014, Zacks Investment Research downgraded LB Foster Co. (FSTR) to a Zacks Rank #5 (Strong Sell) from a Zacks Rank #3 (Hold) primarily driven by woeful quarterly results.
FSTR: 51.81 (-1.69), MTL: 0.84 (-0.04), X: 35.25 (+0.47)

Gerdau Q3 Earnings Fall on Higher costs and Forex Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:40AM CST
Gerdau S.A's (GGB) net income came in at R$262 million (US$115.4 million) for third-quarter 2014, down 59.2% year over year.
GGB: 4.23 (-0.13), FSTR: 51.81 (-1.69), MTL: 0.84 (-0.04), X: 35.25 (+0.47)

L.B. Foster (FSTR) Misses Q3 Earnings on Expense Worries - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:10AM CST
L.B. Foster Company (FSTR) posted adjusted earnings of 88 cents per share for third-quarter 2014, down 7.4% from 95 cents earned in the year-ago quarter.
STLD: 22.34 (-0.07), FSTR: 51.81 (-1.69), NUE: 53.36 (+0.09), MTL: 0.84 (-0.04)

L.B. Foster's (FSTR) CEO Robert Bauer on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 5:31PM CST

FSTR: 51.81 (-1.69)

L.B. Foster (FSTR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 9:55AM CST

FSTR: 51.81 (-1.69)

L.B. Foster misses by $0.14, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:56AM CST

FSTR: 51.81 (-1.69)

L.B. Foster Reports Third Quarter Operating Results
GlobeNewswire - Tue Nov 04, 6:53AM CST
L.B. Foster Company (Nasdaq:FSTR), a leading manufacturer, fabricator, and distributor of products and services for rail, construction, energy and utility markets, today reported its third quarter 2014 operating results, which included income from continuing operations of $0.88 per diluted share, a 7.4% decrease from the third quarter of 2013. Operating cash flow was strong, generating $18.0 million compared to $3.0 million in the prior year third quarter. Sales were $167.8 million, 3.4% higher than the third quarter of 2013.
FSTR: 51.81 (-1.69)

LB Foster Shares Up on Acquisition, 33% Dividend Hike - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 3:34PM CST
LB Foster Co. (FSTR), the premium railroad, tubular and construction product manufacturing firm has increased its quarterly dividend by 33% to 4 cents per share on Oct 31, 2014.
STLD: 22.34 (-0.07), FSTR: 51.81 (-1.69), NUE: 53.36 (+0.09), MTL: 0.84 (-0.04)

Will LB Foster (FSTR) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:47AM CST
Will LB Foster (FSTR) Continue to Surge Higher?
FSTR: 51.81 (-1.69)

L.B. Foster Company declares $0.04 dividend
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 10:02AM CDT

FSTR: 51.81 (-1.69)

L.B. Foster Company Increases Quarterly Dividend
GlobeNewswire - Fri Oct 31, 9:50AM CDT
L.B. Foster Company (Nasdaq:FSTR) announced today that its Board of Directors has authorized a $0.04 per share regular quarterly cash dividend on its issued and outstanding shares of common stock.
FSTR: 51.81 (-1.69)

LB Foster Up 14.3% Since SmarTrend Uptrend Call (FSTR)
Comtex SmarTrend(R) - Fri Oct 31, 9:38AM CDT
SmarTrend identified an Uptrend for LB Foster (NASDAQ:FSTR) on October 16th, 2014 at $47.49. In approximately 2 weeks, LB Foster has returned 14.31% as of today's recent price of $54.28.
FSTR: 51.81 (-1.69)

United States Steel (X) Jumps: Stock Adds 5.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:04AM CDT
United States Steel Corp. (X) was a big mover last session, as the company saw its shares rise over 5% on the day.
FSTR: 51.81 (-1.69), NUE: 53.36 (+0.09), MTL: 0.84 (-0.04), X: 35.25 (+0.47)

L.B. Foster Announces Agreement to Acquire Balfour Beatty Rail GmbH Railroad Tuning Unit (FWO)
Thomson Reuters ONE - Wed Oct 29, 8:00AM CDT
PITTSBURGH, Oct. 29, 2014 (GLOBE NEWSWIRE) -- Pittsburgh, PA-based L.B. Foster Company (Nasdaq:FSTR) today announced an agreement to acquire the railroad tuning unit, FWO, of Balfour Beatty Rail GmbH. The German business provides track lubrication and switch roller equipment for international railway applications.
FSTR: 51.81 (-1.69)

POSCO (PKX) Q3 Earnings Fall Y/Y, 2014 Outlook Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 1:50PM CDT
POSCO (PKX) reported a disappointing third-quarter 2014 results, with net earnings plummeting 60.3% year over year to KRW 224 billion (US$0.22 billion). Earnings came in at KRW 2,567.3 per share or US$0.63 per American Depository Receipt.
FSTR: 51.81 (-1.69), MTL: 0.84 (-0.04), PKX: 67.34 (-0.42)

L.B. Foster Company to Report Third Quarter 2014 Operating Results on November 4, 2014
GlobeNewswire - Wed Oct 22, 11:22AM CDT
L.B. Foster Company (Nasdaq:FSTR), today announced that it will broadcast a conference call to discuss its third quarter 2014 operating results on Tuesday, November 4, 2014 at 11:00am Eastern Time. The Company plans to release its results that same day before the market opens.
FSTR: 51.81 (-1.69)

AK Steel Holding Corporation (AKS) Jumps: Stock Rises 9.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 8:11AM CDT
AK Steel Holding Corporation (AKS) was a big mover last session, as the company saw its shares rise over 9% on the day.
FSTR: 51.81 (-1.69), AKS: 6.32 (+0.08)

L.B. Foster Enters Oversold Territory
MarketNewsVideo.com - Thu Sep 25, 12:39PM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
FSTR: 51.81 (-1.69)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

BioXcel Therapeutics Faces Challenges Amidst 52-Week Low

Updated Category News Views 85

BioXcel Therapeutics: Facing the Heat BioXcel Therapeutics Inc. (BTAI) is in the doghouse—its stock just hit a jaw-dropping 52-week low of $0.53. That's an eye-watering drop of over 80% in the last year. Investors are glued to their screens, weighing whether to grab some shares at rock-bottom prices or steer clear as BioXcel grapples with mounting obstacles. This sharp...

Continue Reading
Guidehouse Welcomes Ron White as New Chief Information Officer

Updated Category News Views 315

Guidehouse Appoints Ron White as Chief Information Officer Advancing the firm's AI-led strategy with visionary leadership to drive business transformation and scalable innovation MCLEAN, Va. – Guidehouse, a global AI-led professional services firm, has recently appointed Ron White as its Chief Information Officer (CIO). With over 35 years of expertise in enterprise...

Continue Reading
Natural Ingredients Driving Growth in Cosmetics Market

Updated Category News Views 186

Market Growth Driven by Consumer Demand Recent studies indicate that the chemicals market for cosmetics and toiletries is experiencing significant growth. The market is set to increase from $27.7 billion to an impressive $35 billion by the end of 2029. This momentum speaks volumes about the trends affecting consumer preferences and the investment patterns of leading...

Continue Reading
Securities Investigation Alert for Semler Scientific Investors

Updated Category News Views 118

Understanding the Semler Scientific Investigation The Rosen Law Firm is actively investigating potential securities claims for investors of Semler Scientific, Inc. (NASDAQ: SMLR). This initiative addresses concerns regarding the possibility that the company may have provided significantly misleading information about its business practices to the public. Why You Should Be...

Continue Reading
Exciting Updates from Bitget Wallet: Join Fomo Thursdays

Updated Category News Views 390

Bitget Wallet Introduces Fomo Thursdays Events Bitget Wallet, a prominent non-custodial crypto wallet, is thrilled to announce the launch of its fourth Fomo Thursdays event, brought to life in collaboration with Velo Protocol. This event focuses on broadening participation in the crypto space, featuring a staggering prize pool of 3.47 million VELO tokens and 50,000 slots...

Continue Reading